dacarbazine has been researched along with Brain Stem Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (15.63) | 29.6817 |
| 2010's | 27 (84.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortunato, JT; Pan, E; Reys, B; Singh, P | 1 |
| Christiansen, H; Kortmann, RD; Kramm, CM; Müller, K; Schlamann, A; Seidel, C; von Bueren, AO; Vordermark, D; Warmuth-Metz, M | 1 |
| Bailey, S; Boota, N; Connolly, DJ; Fisher, D; Gibson, M; Glaser, A; Hargrave, D; Howman, A; Kearns, P; Picton, S; Pizer, B; Saran, F; Wheatley, K; Wherton, D | 1 |
| Blüml, S; Brown, RJ; Dhall, G; Finlay, JL; Wellner, M; Zaky, W | 1 |
| Basso, ME; Bertin, D; Fagioli, F; Mussano, A; Pittana, LS; Vallero, SG | 1 |
| Glück, A; Guckenberger, M; Kortmann, RD; Kramm, C; Müller, K; Pietschmann, S; Schlamann, A; von Bueren, AO; Warmuth-Metz, M; Wawer, A | 1 |
| Altonok, D; Konski, A; Poulik, J; Sood, S; Wang, ZJ | 1 |
| Brügge, D; Hottinger, A; Hundsberger, T; Putora, PM; Roelcke, U; Stupp, R; Tonder, M; Weller, M | 1 |
| Delattre, JY; Laigle-Donadey, F; Martin-Duverneuil, N; Mokhtari, K; Reyes-Botero, G | 1 |
| Attinà, G; Balducci, M; Caldarelli, M; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Riccardi, R; Ridola, V; Rizzo, D; Ruggiero, A; Scalzone, M | 1 |
| Chen, K; Gao, J; Guan, J; He, H; Kong, X; Li, Y; Liu, S; Ma, W; Wang, R; Wang, Y; Xing, B; Yan, C; Yang, Y; Zhou, Q | 1 |
| Backus, L; Chow, LM; DeWire, M; Doughman, R; Drissi, R; Fouladi, M; Goldman, S; Grimme, L; Hummel, TR; Kumar, S; Lane, A; Leach, J; Miles, L; Pai, A; Pruitt, D; Salloum, R; Sobo, M; Stevenson, C; Sutton, M | 1 |
| Bégué, RE; Deputy, S; Toler, J; Zakris, E | 1 |
| Al-Sarraj, S; Bridges, LR; Burford, A; Carceller, F; Fowkes, LA; Hovestadt, V; Jerome, N; Jones, C; Jones, DT; Khabra, K; Koh, DM; Laxton, R; Leach, MO; Mackay, A; Mandeville, H; Marshall, LV; Moreno, L; Pearson, AD; Pfister, SM; Saran, F; Vaidya, S; Zacharoulis, S | 1 |
| Mori, K; Nakao, Y; Wada, R; Watanabe, M; Yamamoto, T | 1 |
| Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T | 1 |
| Banerjee, A; Dinca, EB; Gupta, N; Hashizume, R; James, CD; Ozawa, T; Prados, MD | 1 |
| Chang, FC; Chang, KP; Chen, YW; Chiang, KL; Hsu, TR; Huang, PI; Lee, YY; Wong, TT | 1 |
| Cho, BK; Jung, HL; Kim, CY; Kim, IA; Kim, IH; Kim, SK; Lee, MJ; Lee, MM; Phi, JH; Wang, KC | 1 |
| Bartels, U; Baruchel, S; Bouffet, E; Eisenstat, D; Gammon, J; Huang, A; Hukin, J; Johnston, DL; Samson, Y; Sharp, JR; Stempak, D; Stephens, D; Tabori, U | 1 |
| Chen, Z; Mao, Y; Wang, Y; Wu, J; Yao, Y; Zhang, C; Zhou, L | 1 |
| Abbasova, EV; Govorina, EV; Parkhomenko, RA; Rodionov, MV; Shcherbenko, OI; Zelinskaia, NI | 1 |
| Bouffet, E; Cohen, KJ; Heideman, RL; Holmes, EJ; Lavey, RS; Pollack, IF; Zhou, T | 1 |
| García, S; Garzás, C; Izquierdo, L; López-Laso, E; Mateos, ME; Pérez-Navero, JL | 1 |
| Canale, S; Chassot, A; Dhermain, F; Dufour, C; Grill, J; Negretti, L; Puget, S; Raquin, MA; Rialland, X; Roujeau, T; Varlet, P | 1 |
| Balis, FM; Berg, SL; Boyett, JM; Geyer, JR; Goldman, S; Gururangan, S; Kun, LE; McLendon, RE; Minturn, JE; Packer, RJ; Pollack, IF; Poussaint, TY; Wallace, D; Warren, KE | 1 |
| Aoki, Y; Banerjee, A; Gupta, N; Hashizume, R; James, CD; Ozawa, T; Prados, M | 1 |
| Cai, CL; Fang, HH; Kang, JB; Li, FM; Nie, Q | 1 |
| Bharwani, L; Vellayappan, BA | 1 |
| Aguilera, DG; Esiashivilli, N; Hayes, L; Janns, A; Jordan, C; Macdonald, TJ; Mazewski, C | 1 |
| Belogurova, MB; Borodina, ID; Gorbatykh, SV; Kumirova, EV; Melikian, AG; Prityko, AG; Shcherbenko, OI; Tarasova, IS; Zheludkova, OG | 1 |
| Bowers, DC; Broniscer, A; Chintagumpala, M; Fouladi, M; Gajjar, A; Iacono, L; Krasin, MJ; Stewart, C; Wallace, D | 1 |
1 review(s) available for dacarbazine and Brain Stem Neoplasms
| Article | Year |
|---|---|
Cryptococcemia in a patient with glioblastoma: case report and literature review.
Topics: Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Central Nervous System; Cryptococcosis; Dacarbazine; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy; Temozolomide; Tomography, X-Ray Computed | 2012 |
8 trial(s) available for dacarbazine and Brain Stem Neoplasms
| Article | Year |
|---|---|
Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Female; Glioma; Humans; Karnofsky Performance Status; Male; Quality of Life; Remission Induction; Survival Analysis; Temozolomide; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2013 |
A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Korea; Male; Pons; Temozolomide; Thalidomide | 2010 |
A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Canada; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Female; Glioma; Humans; Infant; Male; Maximum Tolerated Dose; Pilot Projects; Temozolomide; Thrombocytopenia; Treatment Outcome | 2010 |
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Female; Humans; Male; Pons; Radiotherapy Dosage; Survival Rate; Temozolomide; Treatment Outcome | 2011 |
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Topics: Adult; Antineoplastic Agents; Brain Stem Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Neoplasm Grading; Pons; Temozolomide | 2012 |
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
Topics: Adolescent; Antineoplastic Agents; Brain Stem Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Drug Therapy, Combination; Female; Glioma; Guanine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Male; Proportional Hazards Models; Retrospective Studies; Temozolomide; Tumor Suppressor Proteins; Young Adult | 2012 |
[Safety and efficacy of three-dimensional conformal radiotherapy combined with temozolomide in treatment of diffuse brainstem gliomas].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Injuries; Brain Stem Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Radiation Injuries; Radiotherapy, Conformal; Remission Induction; Survival Rate; Temozolomide; Young Adult | 2011 |
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Camptothecin; Child; Child, Preschool; Dacarbazine; Female; Glioma; Humans; Infusions, Intravenous; Irinotecan; Male; Temozolomide; Treatment Outcome | 2005 |
23 other study(ies) available for dacarbazine and Brain Stem Neoplasms
| Article | Year |
|---|---|
Brainstem Glioblastoma Multiforme in a Patient with NF1.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Stem; Brain Stem Neoplasms; Chemoradiotherapy; Codon, Nonsense; Dacarbazine; Glioblastoma; Humans; Male; Neurofibromin 1; Temozolomide; Young Adult | 2018 |
Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma. A compassionate use treatment.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Female; Glioma; Humans; Spinal Neoplasms; Temozolomide; Treatment Outcome | 2013 |
Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Stem Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Irinotecan; Male; Radiography; Retrospective Studies; Survival Rate; Temozolomide | 2013 |
Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Child; Dacarbazine; Female; Glioma; Humans; Male; Pons; Retrospective Studies; Survival Analysis; Temozolomide | 2014 |
Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Female; Glioma; Humans; Male; Radiotherapy, Conformal; Survival Rate; Temozolomide; Treatment Outcome | 2014 |
Inadvertent high-dose therapy with temozolomide in a child with recurrent pontine glioma followed by a rapid clinical response but deteriorated after substitution with low-dose therapy.
Topics: Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Child; Dacarbazine; Dose-Response Relationship, Drug; Fatal Outcome; Glioma; Humans; Male; Neoplasm Recurrence, Local; Temozolomide | 2014 |
Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Stem; Brain Stem Neoplasms; Dacarbazine; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Retrospective Studies; Switzerland; Temozolomide; Treatment Outcome; Young Adult | 2014 |
Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Stem; Brain Stem Neoplasms; Combined Modality Therapy; Dacarbazine; Databases, Factual; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Temozolomide; Treatment Outcome; Young Adult | 2014 |
Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Stem; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Dacarbazine; Disease Progression; Female; Follow-Up Studies; Glioma; Hospitals, Religious; Hospitals, University; Humans; Male; Neoplasm Grading; Neurons; Prognosis; Prospective Studies; Rome; Survival Analysis; Temozolomide | 2015 |
Brain Stem and Entire Spinal Leptomeningeal Dissemination of Supratentorial Glioblastoma Multiforme in a Patient during Postoperative Radiochemotherapy: Case Report and Review of the Literatures.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Brain Stem Neoplasms; Chemoradiotherapy; Cisplatin; Dacarbazine; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Temozolomide | 2015 |
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Stem Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Dacarbazine; Female; Follow-Up Studies; Glioma; Humans; Irinotecan; Male; Neoplasm Grading; Pilot Projects; Prognosis; Survival Rate; Temozolomide; Young Adult | 2016 |
Cognitive Dysfunction After Cranial Radiation for a Brain Tumor.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Brain Stem Neoplasms; Cognitive Dysfunction; Cranial Irradiation; Dacarbazine; Delirium; Dexamethasone; Diagnosis, Differential; Encephalitis, Herpes Simplex; Female; Glioma; Herpesvirus 1, Human; Humans; Leukocytosis; Magnetic Resonance Imaging; Seizures; Temozolomide; Young Adult | 2016 |
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioma; Histones; Humans; Infant; Male; Radiotherapy; Risk Factors; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins; Young Adult | 2016 |
Intra-axial brainstem malignant melanoma mimicking cavernous angioma--case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Diseases; Craniotomy; Dacarbazine; Diagnosis, Differential; Female; Hemangioma, Cavernous, Central Nervous System; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Melanoma; Nimustine; Radiotherapy, Adjuvant; Reoperation; Tamoxifen | 2008 |
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome | 2009 |
A human brainstem glioma xenograft model enabled for bioluminescence imaging.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Cell Line, Tumor; Dacarbazine; Diagnostic Imaging; Disease Models, Animal; Glioma; Humans; In Situ Nick-End Labeling; Kaplan-Meier Estimate; Luciferases; Luminescent Agents; Male; Neoplasm Transplantation; Rats; Rats, Nude; Temozolomide; Time Factors; Xenograft Model Antitumor Assays | 2010 |
Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Radiotherapy; Retrospective Studies; Temozolomide; Treatment Outcome | 2010 |
Temozolomide for adult brain stem glioblastoma: case report of a long-term survivor.
Topics: Antineoplastic Agents, Alkylating; Brain Stem Neoplasms; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Survival Rate; Temozolomide; Treatment Outcome; Young Adult | 2010 |
[Efficiency of radiation or chemoradiation therapy for diffusely growing brainstem tumors in children].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Brain Stem Neoplasms; Chemotherapy, Adjuvant; Child; Dacarbazine; Disease Progression; Humans; Temozolomide; Treatment Outcome; Vincristine | 2008 |
Response to nimotuzumab in a child with a progressive diffuse intrinsic pontine glioma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Dacarbazine; Disease Progression; ErbB Receptors; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Pons; Temozolomide | 2011 |
An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing.
Topics: Animals; Antineoplastic Agents; Brain Stem Neoplasms; Caspase 3; Cyclin-Dependent Kinase Inhibitor p16; Dacarbazine; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Luminescent Agents; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Piperazines; Pons; Pyridines; Retinoblastoma Protein; Temozolomide; Time Factors; Tumor Cells, Cultured; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2012 |
Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Stem Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Pons; Prognosis; Survival Rate; Temozolomide | 2013 |
[Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Dacarbazine; Data Interpretation, Statistical; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide; Time Factors | 2002 |